Research News - February 26, 2021

 

         
 
February 26, 2021
ANNOUNCEMENTS
 

1. COVID-19 Testing for Asymptomatic MGH Employees in the Charlestown Navy Yard
2. Requesting Extensions for Early Career Scientists Whose Career Trajectories Have Been Significantly Impacted by COVID-19 (NIH)
3. Harvard Catalyst Clinical Trial Design Course—Applications Now Open
4. NEW RISC data catalog platform is now available for MGB researchers
5. MGH Center for Comparative Medicine (CCM) Animal Bioware Ordering Web Site – Scheduled Maintenance
6. Notice of Intent to Publish Research Opportunity Announcements (OTA-21-015) for the Post-Acute Sequelae of SARS-CoV-2 Infection (PASC) Initiative
7. Position Opening - Director, Division of Clinical Research
8. New TEDxMGH Talk! My Journey with Depression.

EVENTS
 

1. Post-Acute Sequelae of COVID Town Hall Meeting
2. QI Bootcamp for Clinical Researchers and Study Staff
3. Maurizio Fava Lecture Series on Well-Being
4. IDEA Symposium: Digital Health Innovation in the Age of COVID-19
5. ThuRsday R's Day: Weekly Training Sessions
6. 3rd Annual Clinical Research Nurse Meeting – Making Clinical Research Transgender Inclusive
7. Virtual Visits
8. Anne Klibanski Visiting Lecture Series 3
9. Introduction to Python series
10. Equity Access and Inclusion in Digital Health
11. Save the Date – 2021 Celebration of Science and Scientific Advisory Committee Meeting
12. Save the Date: 5th Annual Diversity, Equity & Inclusion Summit
13. Register now for the 22nd Annual Harvard Nutrition and Obesity Symposium: Global Food Systems and Sustainable Nutrition in the 21st Century

FUNDING OPPORTUNITIES
 

1. COVID Funding Opportunities
2. Fund for Medical Discovery (FMD) Research Fellowship Awards
3. 2021 Physician/Scientist and Clinician-Teacher Development Awards; Consultation service available for the potential applicants
4. NIH Instrumentation Grant Programs 2021
5. Gerstner Scholar Award
6. 2021 Blavatnik Therapeutics Challenge Awards
7. Breast Cancer Alliance – Exceptional Project Grants
8. Thinking about an EBP, QI, or research project? Special funding opportunity for DNP & advanced practice nurses!
9. HMS Foundation Funds
10. NIH Research Supplements to Promote Diversity in Health-Related Research
11. The Yvonne L. Munn Predoctoral Research Grant for PhD Nursing Students
12. Strengthen research skills, support health equity with the 2021 Butler-Williams Scholars Program
13. Limited Submission Funding Opportunities
14. Foundation Funding Opportunities

In Case You Missed It
 
Reminders of recently posted funding opportunities, deadlines and events
 
ANNOUNCEMENTS
 
1. COVID-19 Testing for Asymptomatic MGH Employees in the Charlestown Navy Yard

We are pleased to report that on-site COVID-19 testing for asymptomatic (no COVID symptoms) MGH employees will be expanded to the Charlestown Navy Yard free of charge.  The testing is for asymptomatic employees who do not fall into the categories listed below.

  • Symptomatic employees who have even minor symptoms of COVID-19 should stay home and contact the Occupational Health Services (OHS) Call Center at 617-724-8100.
  • Asymptomatic employees with confirmed exposures (occupational or community) should contact the OHS Call Center at 617-724-8100 to be scheduled for testing.
  • Testing for clinical reasons (for example, if an employee requires pre-admission or pre-procedural testing) will continue to be ordered by your provider and should not be completed at the Employee Testing Center.

For the next few weeks, the schedule will be as follows.

Friday, February 26, 11:00 AM – 1:00 PM
Tuesday, March 2, 11:00 AM – 1:00 PM
Friday, March 5, 11:00 AM – 1:00 PM
Tuesday, March 9, 11:00 AM – 1:00 PM
Friday, March 12, 11:00 AM – 1:00 PM

Testing Location - CNY 114 Cafeteria (1st Floor)

Testing will be done on a walk-in basis.  No appointment is needed.  Your employee ID is required.  We do ask if the line is long, you come back at a later time.

The testing process will be managed through the Labpass web portal.  You will need to set up an account in Labpass.  Registration for each test will be done at the testing site.

How to create an account in Labpass

  • Account activation/set up and results delivery will be managed through secure patient accounts in Labpass. Visit Apollo for more information about using Labpass.  Note: Information in Apollo on scheduling an appointment in Labpass is not applicable for the CNY walk-in site.
  • Start your account set up here (copy and paste this link into Chrome, it will not open properly in Internet Explorer): https://www.labpass.com/en/login, and enter the following access code: MGHEmployee
    • You will receive confirmation and account activity emails from Support@ LabPass.com. Please check your spam folder for these emails and mark "Not Spam" to ensure you receive important notifications.
  • Your email address must be entered correctly for you to receive account activation links and confirmation emails, including access to your test results.

This site is not compatible with Internet Explorer. Staff must use Google Chrome, Mozilla FireFox, Apple Safari, or Microsoft Edge.

Helpful Resources
For assistance or questions with setting up your Labpass account for the CNY 114 testing site please contact researchmanagement@mgh.harvard.edu. Please include your name, phone number and a brief description of the issue.
 
For questions about your results, or difficulty accessing results in Labpass, contact OHS at PHSOHSCOVID19@partners.org. Please include the following information:

  • Subject line: Labpass Results - MGH
  • Body of email: Name and date of birth, email address you registered with and what the general issue is (unable to access results or other)
We expect to continue testing past the initial 2 weeks.  Stay tuned for the schedule moving forward.  We will continue to keep you up-to-date with any changes or additions as this new program progresses.
 
2. Requesting Extensions for Early Career Scientists Whose Career Trajectories Have Been Significantly Impacted by COVID-19 (NIH)

The COVID-19 pandemic, along with extensive mitigation measures, has adversely affected progress in many biomedical research settings. Evidence from multiple sources, including a survey NIH issued to its extramural research workforce, indicates legitimate concerns about career trajectory for early career scientists. Therefore, within existing constraints of available funding, NIH plans to support early career scientists whose career trajectories have been significantly affected by the pandemic.

NIH is providing an opportunity for recipients of NIH Fellowship (“F”) and NIH Career Development (“K”) awards who have been impacted by COVID-19 to request extensions. To learn more about the process, click here.

 
3. Harvard Catalyst Clinical Trial Design Course—Applications Now Open

Clinical Trial Design (CTD) is an opportunity for new clinical investigators, who have an idea for development of a clinical trial, to participate in an intensive nine-week course. Participants will learn the fundamentals of clinical trial design, including instructions on how to design a protocol, information on IRB and regulatory topics, and on trial implementation. Additional course topics include statistical analysis, budgeting, and data management.

Applications due March 5, 2021. Free for Harvard-affiliated institutions. https://catalyst.harvard.edu/services/ctd/

 
4. NEW RISC data catalog platform is now available for MGB researchers

We proudly present RISC Dashboard: Research Information Science and Computing hosted by Collibra. The new data catalog tool is becoming a central location for the data definitions for assets within RISC repositories, starting with COVID-19 research tools and the RPDR data dictionaries. Any Mass General Brigham researcher has access to navigate to multiple data dictionaries, where the information is displayed in an organized and concise view. This allows researchers, like you, to get better visibility into everything we have to offer. You are able to review available data for your research evaluation without the need to get access to the data itself.  The tool currently contains some RISC data dictionaries, application dashboards, and MORE! The Tutorial Video may be a good starting point!  Future expansion of this valuable platform will allow the RISC team to help you broaden and optimize your research data discovery and exploration.

 
5. MGH Center for Comparative Medicine (CCM) Animal Bioware Ordering Web Site – Scheduled Maintenance

On Friday, 3/5/2021 from 3:30pm – 5:30pm CCM will be performing an upgrade to the Animal Bioware web application.

This change will enable you to use your existing Mass General Brigham (MGB) domain account credentials to login into the Animal Bioware web site.

To login, simply use your Mass General Brigham (MGB) domain account credentials (login ID/password).  Please note, you must be listed on an active protocol within Insight to be able to use this system.

If you have any questions or problems, please email us at CCMITSUPPORT@PARTNERS.ORG

 
6. Notice of Intent to Publish Research Opportunity Announcements (OTA-21-015) for the Post-Acute Sequelae of SARS-CoV-2 Infection (PASC) Initiative

The NIH recently announced that they will publish several Research Opportunity Announcements (ROAs) as part of its new Post-Acute Sequelae of SARS-CoV-2 Infection (PASC) initiative. According to the NIH “This Notice is to alert the community that NIH plans to publish Research Opportunity Announcements (ROAs) as part of the Post-Acute Sequelae of SARS-CoV-2 Infection (PASC) initiative. The solicited research will improve understanding of and develop strategies to prevent and treat post-acute manifestations of SARS-CoV-2 infection across the lifespan. The initial ROAs are expected to be published by mid-February 2021. Projects will be funded utilizing NIH’s Other Transaction Authority (OTA), which offers flexibility and the ability to engage partners in collaborative innovation and problem solving. Initial awards are anticipated to be made in early March 2021. This Notice is being provided for informational purposes to allow potential applicants additional time to develop responsive applications.”

For more information on the upcoming ROAs, click here. We encourage you to review this notice and consider whether you would be eligible for one or more of these opportunities.

Please keep an eye on Research News for the official ROA announcement.

 
7. Position Opening - Director, Division of Clinical Research

Massachusetts General Hospital (MGH) is recruiting a new Director for the Division of Clinical Research (DCR). In this leadership role, the new Director will set and carryout the vision for the support of clinical research at MGH. The principle responsibilities of this position include:

  • To develop and sustain a compelling vision for how to address the future needs of human investigation at the MGH;
  • To implement that vision in collaboration with the DCR Director of Operations and Faculty;
  • To modify this vision and programs over time in response to the every-changing environment and opportunities of our hospital.
  • The DCR Director is responsible for co-chairing the Clinical Research Council alongside the SVP for Research. 
  • The DCR Director will chair the Committee on Clinical Research, comprising representatives from all departments with clinical research programs.
  • The DCR Director will chair an Executive Committee on Clinical Research that will consist of the Center and Unit Directors of the DCR, the Directors of the Translational and Clinical Research Centers, The SVP for Research and two representatives from the Executive Committee on Research (ECOR) leadership.
  • The DCR Director will work closely with the Directors of the Translational Research Center and the Clinical Research Center to align resources and offerings to support the clinical research mission.
  • The DCR Director will be an ex-officio member of ECOR, a member of ECOR’s executive staff, a member of the Research Institute Steering Committee, and an ex-officio member of Chief’s council.
  • This position will have a reporting structure similar to that of the Thematic Center Directors, reporting to the SVP for Research and ECOR Chair.
  • To increase the quantity and quality of all forms of clinical research at the MGH (including translation, clinical trials, epidemiology, safety and quality outcomes and population studies).
  • To assist the Department Chiefs and Center Directors in recruiting the best and brightest physician scientists and basic investigators to careers in clinical research.
  • To provide an institutional infrastructure and milieu to facilitate their retention.

Qualifications
The successful candidate will have: an MGH appointment, a compelling strategic vision for the MGH’s translational research future and an operational plan; a track record of a national presence and experience with NIH and industry-sponsored clinical research is preferred; experience running a robust clinical research program; and a track record of mentorship. Long-term clinical research experience is preferred. Leadership and team management expertise required. It is anticipated that the successful candidate will have qualifications consistent with the rank of Associate Professor or Professor Harvard Medical School and devote up to 50% time to the position.

Department Overview
The Division of Clinical Research (DCR) of the Mass General Research Institute works to promote science at the clinical-research interface. The division sponsors a total of 10 centers and 14 units, each of which has a specific mission to assist investigators conducting clinical research.

Our mission is to increase the quality, quantity, and efficiency of translating basic science advances into improved care for our patients. Our researchers and clinicians partner with academia, industry, governments, foundations, and philanthropists to prevent and treat disease, and improve the lives of our patients.

For further information about the DCR centers/units and education/training opportunities, visit their website at: https://www.massgeneral.org/research/division-clinical-research/

How to Apply
Interested candidates should email a C.V. and cover letter to:

Merit Cudkowicz, MD, MDc
Chief, Neurology Service
MGHDCRDirectorSearch@partners.org

 
8. New TEDxMGH Talk! My Journey with Depression

Dr. Shannon Scott-Vernaglia, a physician/patient, educator/learner, mother/daughter, talks about her journey through depression, and her choice to talk about it openly. View video here. The TEDxMGH videos present inspirational stories from the MGH community, including how people have handled challenges through innovation, resilience, vulnerability, and connection. These monthly 10-12 min. stories by your colleagues cover far-reaching topics – from antiracism and social justice to climate change, laughter, coping with loss, COVID-19, and living and working with depression. 

Back to top
EVENTS
 
1. Post-Acute Sequelae of COVID Town Hall Meeting

Friday, February 26, 4:30 – 5:30 PM, Zoom

The NIH has identified post-acute COVID-19 syndrome as a major priority for this year and has published two RFAs: OTA-21-015A and OTA-21-015B. With the deadlines for submissions ranging from March 16 to March 23 and with funding support available as early as April, all interested clinicians, researchers and staff are invited to participate in this roundtable discussion to help MGH identify priorities/challenges and build the collaborations and infrastructure necessary to respond to
the NIH’s call and address the urgent clinical needs of this growing patient population.

Please, join us for the Post-Acute Sequelae of COVID Town Hall.

Panel: Maggie Alegria, Ingrid Bassett, Andrea Foulkes, Ken Freedberg, Steve Grinspoon, Shawn Murphy, Roy Perlis, and Jonathan Rosand

Please register in advance for this meeting: https://partners.zoom.us/meeting/register/tZErdu6hqDMqEtzUlTxUvS6oUHwKk62Nkhsj

After registering, you will receive a confirmation email containing information about joining the meeting.

 
2. QI Bootcamp for Clinical Researchers and Study Staff

Monday, March 1, 2021, 10:00 AM – 12:30 PM, Zoom

Speaker: Pamela Richtmyer, Director, Mass General Brigham Human Research Quality Improvement Program

The QI Program Clinical Research Bootcamp is a “clinical research 101” for study staff and investigators. The course is not only an introduction to clinical research for new investigators and study staff but also good review for experienced study teams.  Many teams include this course as part of the onboarding process for new study staff.  The course covers research regulations, GCP guidelines, and institutional policies relevant to  the day to day conduct of clinical research.  Topics include:

  • Informed Consent documentation
  • Study Documentation (subject files, source documents, and data collection forms)
  • Unanticipated Problems, Deviations and Violations
  • Investigational Product Management and Accountability
  • Regulatory Binder and Essential Documents
  • ClinicalTrials.Gov
  • Inspections and audits 
  • Other relevant topics

Register here. Please contact  Tiereny Morrison-Rohlfs with any questions.

Click here to learn more about QI Bootcamp for Clinical Researchers and Study Staff

 
3. Maurizio Fava Lecture Series on Well-Being

Tuesday, March 2, 2021, 12:00 – 1:00 PM, Zoom

Sponsored by the Center for Faculty Development's Office for Well-Being

"The Pursuit of Euthymia: How Can We Keep Our Values and Well-Being in Academia?"

The Maurizio Fava Lecture Series on Well-Being, created to honor Dr. Fava’s vision and advocacy for well-being of the MGH community, will be inaugurated with a lecture by Dr. Giovanni Fava titled “The Pursuit of Euthymia – How can we keep our values and well-being in academia?”. 

Professor of Clinical Psychology at the University of Bologna, with a joint appointment at the State University of New York at Buffalo as Clinical Professor of Psychiatry, Dr. Fava has authored more than 500 scientific papers and performed groundbreaking research in several fields, including the introduction of a novel psychotherapeutic approach, Well-Being Therapy. He is Editor-in-Chief of Psychotherapy and Psychosomatics. 

Click here to join the Zoom meeting

Register and add to my calendar  
 
4. IDEA Symposium: Digital Health Innovation in the Age of COVID-19

Wednesday, March 3, 2021, 3:00 PM, Zoom

“Digital Health Innovation in the Age of COVID-19” will highlight some of the new infrastructures for digital health, including research, and will feature Shawn Murphy, MD, PhD, Chief Research Information Officer, MGB; Adam Landman, MD, Chief Information Officer; Digital Innovation Officer BH; Lee Schwamm, MD, VP, Virtual Care, MGB.

Click here to register.

Mass General Brigham Innovation Digital Education Academy (IDEA) is a new, year-long program focused on Innovation and Digital Health. Each month, we will host a special session highlighting key individuals and innovations happening within the digital health space. 

Click here to learn more.
 
5. ThuRsday R's Day: Weekly Training Sessions

Thursday, March 4, 2021, 11:00 AM – 12:00 PM, MS Teams

These weekly sessions are a mix of training and show-and-tell for learning useful R tips just like the Enterprise Research IS R User Group Meeting. R is a free and open programming language for statistical computing, data analysis, and graphical visualization. In this weekly meeting, one small topic is covered at one time (45 min - 1 hr) in a very friendly, relaxed way so that many beginners can join without any difficulties. Topic and level of difficulty will be announced a couple of days before so that you know what to expect ahead. No need to register. Anybody can join; see MS Teams Meeting information for details (Mass General Brigham login will be required to access the meeting link). 

Click here to learn more about ThuRsday R's Day: Weekly Training Sessions

 
6. 3rd Annual Clinical Research Nurse Meeting – Making Clinical Research Transgender Inclusive

Thursday, March 5, 2021, 5:30 PM – 7:00 PM, Zoom

Co-hosted by the Yvonne L. Munn Center for Nursing Research, the Boston/New England chapter of the International Association of Clinical Research Nurses, and the MGH Clinical Research Nurse Collaborative. Speakers from MGH and Boston Children’s Hospital will facilitate an important discussion on transgender inclusivity in clinical research. All are welcome and encouraged to attend. 1.0 CNE will be awarded following completion of the event. Contact cngrant@mgh.harvard.edu with any questions.

For more information and to RSVP, please click here.  

 
7. Virtual Visits

Monday, March 8, 2021, 10:00 – 11:00 AM, Zoom

Speaker: Pamela Richtmyer, Director, Partners Human Research Quality Improvement Program
The Virtual Clinical Research Visits course will discuss best practices and special considerations for remote clinical research study visits including obtaining consent.  We will also discuss documentation and training requirements as well as recently released FDA requirements for remote visits. 
Register here. Please contact Tiereny Morrison-Rohlfs with questions.

Click here to learn more about Virtual Visits

 
8. Anne Klibanski Visiting Lecture Series 3

Tuesday, March 9, 2021, 12:00 – 1:00 pm, Zoom

Sponsored by the Center for Faculty Development

"Analysis of Neurodevelopment and Neurodegeneration on Brain Imaging Using Machine Learning" 

The Anne Klibanski Visiting Lecture Series was created to support and advance the careers of women. These lectures bring together faculty from institutions that have hosted Anne Klibanski Scholars with MGH scholars, on topics that overlap both research areas. Faculty from the outside host institutions are also invited to present on their own. 

This lecture will be given by Lilla Zollei, PhD, Assistant Professor of Radiology, MGH/HMS and Esther E. Bron, PhD, Assistant Professor of Radiology & Nuclear Medicine, Erasmus University Medical Center. The joint title of their talk is "Analysis of neurodevelopment and neurodegeneration on brain imaging using machine learning." 

Click here to join the Zoom webinar

Register and add to my calendar

 
9. Introduction to Python series

Tuesday, March 9, 16, 23 & 30, 2:00 – 3:00 PM, Zoom

Python has been really popular in recent years not only of its powerful ability to manipulate data in a relatively easy and fast manner but also because of its statistical capability, and its ability to utilize a wide variety of packages for all tasks. Python is a programming language that lets you work quickly and integrate systems more effectively. In these four 1 hour training sessions, we will do a very basic hands-on demonstration of Python. 

Click here to learn more.

 
10. Equity Access and Inclusion in Digital Health

Tuesday, March 30, 2021, 12:30 PM, Zoom

“Equity Access and Inclusion in Digital Health” will feature Sandy Aronson; Joe Betancourt, MD; Lee Park, MD; Cheryl Clark, MD; and Jorge Rodriguez, MD, discussing digital health access and impacts particularly from the perspective of patient care.

Click here to register.

 
11. Save the Date – 2021 Celebration of Science and Scientific Advisory Committee Meeting

Wednesday and Thursday, April 7 & 8, 2021, Zoom

We hope you will join us for the 72nd Scientific Advisory Committee Meeting and Celebration of Science.  All events will be held virtually.

Please continue checking the SAC page on the ECOR website for updates regarding this event.

 
12. Save the Date: 5th Annual Diversity, Equity & Inclusion Summit

Wednesday and Thursday, May 19 & 20, 2021, 8:30 am – 12:00 pm, Virtual

Participate in this year’s virtual Diversity, Equity & Inclusion Summit on May 19 and 20, 8:30 a.m.- noon, for two days of learning and engagement. Mass General Brigham has identified diversity, equity and inclusion as focus areas of the highest priority that are aligned with the goals of United Against Racism.

Save the date for this can’t-miss two-day event that will feature:

  • Isabel Wilkerson, Author of Caste
  • Leana Wen, MD, CNN Commentator
  • David Williams, PhD, MPH, Harvard T. H. Chan School of Public Health

For more information, email diversityinclusion@partners.org.

 
13. Register now for the 22nd Annual Harvard Nutrition and Obesity Symposium: Global Food Systems and Sustainable Nutrition in the 21st Century

Tuesday, June 15, 2021, 8:00 AM – 5:30 PM, Virtual

The Nutrition Obesity Research Center at Harvard (NORCH) is pleased to announce our 22nd Annual Symposium, entitled "Global Food Systems and Sustainable Nutrition in the 21st Century." We have an outstanding lineup of speakers who are experts in the fields of public health, global food systems, nutritional inequities, and sustainable nutrition.

Registration is now open. We are expected a high volume of attendees and encourage you to secure your spot early. Click here to register now.

Additional event info and speaker information can be found here.

 
Back to top
FUNDING OPPORTUNITIES
 
1. COVID Funding Opportunities

Please visit the new MGB web page for COVID funding opportunities that provides a central database for researchers to view open and competitive funding announcements.

We have aggregated opportunities from federal and private funding sources including NIH, DoD, CDC, EPA, foundations, and more.  The database defaults to sorting by award amount and can also be sorted by deadline or filtered by research focus.

Upcoming deadlines:

Recently added:

 
2. Fund for Medical Discovery (FMD) Research Fellowship Awards

Applications are now being accepted by the Executive Committee on Research (ECOR) for the Fund for Medical Discovery (FMD) Research Fellowship Awards!

What are they?
New for 2021!  We recognize that research at MGH integrates the full translational spectrum of discovery from "bench to bedside to community and population.” To ensure that all areas of research conducted at MGH are included and eligible for FMD fellowship awards, ECOR is now offering 3 types of training awards: fundamental research fellowships, clinical research fellowships, and population healthcare sciences fellowships. These fellowships are for MD and PhD Research Fellows and Clinical Research Fellows who are in the training phase of their research at MGH and Instructors who are within 5 years total since initiating their research fellowship training.  

How much is each award?
The award will include a stipend of $52,704 plus applicable fringe benefits and 15% indirect costs.

When is the deadline?
Tuesday, March 30, 2021 - 5:00 PM

How do I learn more and apply?
Click here to read more and apply online!

For a guide to help make your application more competitive click here. 
 
3. 2021 Physician/Scientist and Clinician-Teacher Development Awards; Consultation service available for the potential applicants

The MGH and the Center for Diversity and Inclusion (CDI) are committed to retaining and developing faculty who are underrepresented in medicine as investigators, clinicians, teachers and administrative leaders. The Office of the President, MGPO, ECOR, and CDI are pleased to announce the two awards under the 2021 CDI Faculty Development Award Program

Application Deadline: Tuesday, March 9, 2021 at 5:00 pm.

1. The MGH Physician/Scientist Development Award (PSDA):  provides transitional grant funding which will aid the applicant (fellow or junior faculty) in becoming an independent investigator at MGH. Up to $180,000 plus 15% indirect costs will be awarded to be spent over a three or four-year period, with a maximum of $60,000 plus indirect costs per year for 3 year awards and a maximum of $45,000 plus indirect costs per year for 4 year awards. As approved by the MGH Chiefs of Service, four awards will be funded via a 50% cost share between ECOR and the applicant's department. Cost sharing exceptions will be considered if departmental resources are an issue. To submit a PSDA application, please click here.

2. The MGH Clinician-Teacher Development Award (CTDA): provides funding support for a clinical, educational or community project to a faculty member (junior and mid-career), fellow, or graduating resident pursuing an academic career as a clinician, teacher, administrative or community leader at MGH. Up to $120,000 plus 15% indirect costs will be awarded to be spent over a four-year period, with a maximum of $30,000 plus indirect costs per year. Two awards will be funded by the MGPO.  To view and download the 2021 CTDA Application, please click here.

Although eligibility requirements for each award may differ, a key requirement for both awards is the department Chair's commitment to retain the candidate as faculty and to support and develop the applicant's academic career at MGH.

The Awardee must present a talk at least once during the tenure of their award to the Chester Pierce Research Society, an interdepartmental forum for UIM researchers at MGH; and a poster at the CDI’s annual Fall Welcoming and Recognition Reception each year, with the exception of the award year. The Awardee must also comply with all CDI requests pertaining to this Award.

For more information about the CDI Faculty Development Award Program or to download applications, please visit our website.

You may also learn more about these awards by viewing this Zoom recording of the panel session with past PSDA and CTDA recipients held on Jan. 5, 2021.

In addition, the CDI is offering the 2021 CDI Faculty Development Award Consultation Service-
If you are applying for the Clinician-Teacher or Physician/Scientist Development Awards, or have questions about the process, the CDI encourages you to take advantage of the pre-award Consultation Service for potential applicants.

This service is designed to help 2021 applicants develop a strong application for the Clinician-Teacher and the Physician-Scientist Development Awards. Through this service, you can speak with an Award alumna for advice on your application including your research plan, personal statement, and letters.

Please complete this online survey form to help us provide you with the best consultation possible: https://www.surveymonkey.com/r/2021CFDAConsultation

We look forward to receiving applications from eligible candidates supported by their departments. Should you have any questions about these awards, please contact Elena Olson, CDI Executive Director, at ebolson@partners.org.

 
4. NIH Instrumentation Grant Programs 2021

Pre-applications are now being accepted by the Executive Committee on Research (ECOR) for NIH Shared Instrumentation Grants (S10) and the High-End Instrumentation Grants (HEI) Program

The NIH ORIP's Shared Instrumentation Grant (S10) program, also known as a SIG, supports the purchase of research equipment in the $50,000 to $600,000 price range. Examples of instrumentation supported by SIG funding include nuclear magnetic resonance systems, electron and light microscopes, mass spectrometers, protein and DNA sequencers, biosensors, X-ray diffractometers and cell sorters. For research equipment exceeding the $600,000 price range, investigators may apply for the High-End Instrumentation (HEI) Grant Program.

The MGH Executive Committee on Research (ECOR) has again committed funding to provide institutional support this year for Shared Instrumentation Grant (S10) and High-End Instrumentation (HEI) Grant  proposals. ECOR has made this commitment because it recognizes that institutional support greatly increases the likelihood that an application will be funded.

When is the deadline?

ECOR Pre-application Deadline:  Wednesday, March 31, 2021, 5pm
NIH Application Deadline:  Tuesday, June 1, 2021

How to Apply
To submit a pre-application for S10 and HEI grants Click here

If you have questions, please contact MGH ECOR at ecor@mgh.harvard.edu or call 617-643-7420

 
5. Gerstner Family Foundation Scholar Award

Applications are now being accepted by the Department of Psychiatry for the
Gerstner Family Foundation Scholar Award

The Department of Psychiatry requests applications for the 2021 Gerstner Scholar Award, a competitive grant award geared to newly or recently trained MDs or PhDs who seek to pursue careers as clinician-researchers or researchers in the areas of attention deficit hyperactivity disorder (ADHD) and/or ADHD plus related disorders. Past awards have included projects related to screening, mechanisms, basic science/translational, and intervention studies. Funded by The Gerstner Family Foundation, the Award Program honors the memory and the research interests of the late Louis V. Gerstner III. A minimum of two, 2-year awards yearly will be granted.

Award Parameters This is a two-year competitive award for MD- and PhD-level junior faculty who are within five years of completing training. Qualified applicants will have an interest in ADHD and related co-morbidities and a demonstrated commitment to clinical research through past projects and publications. Special attention will be paid to applications with specific interest in the overlap of ADHD and addictive disorders.

  • Applicants must have faculty appointments at Massachusetts General Hospital (MGH).
  • Awards will be for $75,000 per year for two years and may be used for an original research project or to broaden or supplement an existing project. Funding may be used for direct salary and fringe support of the Scholar or for related costs such as research assistant time/effort, biostatistical services, neuroimaging, genetic analysis and travel to scientific meetings.
  • Scholars will conduct clinical or translational research related to core ADHD and/or ADHD plus comorbidity.
  • Scholars will spend at least 50 percent of their time in the conduct of clinical research.
  • Scholars will be mentored by midlevel or senior faculty at the MGH.

Application requirements will include:

  • Application form
  • One-page statement of applicant’s research interests
  • One-page budget
  • Applicant’s curriculum vitae
  • Letter of support by MGH mentor
  • Additional letter of support if a co-mentor or co-investigator is involved in the project

Application Deadline: February 28, 2021

For more information, please feel free to contact Timothy Wilens, MD (twilens@mgh.harvard.edu) or Janet Wozniak, MD (jwozniak@mgh.harvard.edu) with a copy to Nina Deppe (ndeppe@mgh.harvard.edu).

All information can be sent electronically via email to both Drs. Wilens and Wozniak, with a copy to Ms. Deppe.

 
6. 2021 Blavatnik Therapeutics Challenge Awards

The Blavatnik Therapeutics Challenge Awards are part of the historic $200 million commitment from the Blavatnik Family Foundation to HMS, will help propel the School’s mission of transforming health through curiosity-driven research that stimulates the development of new therapies and the creation of new tools to diagnose, prevent, and treat disease.

What is the Award?
The intent of these awards is to accelerate the development of therapeutics throughout HMS and its affiliated hospitals, with the goal of achieving licensable intellectual property and potentially creating new companies within a two-year time frame. The awards program will help investigators overcome obstacles to commercial translation by funding promising technologies and positioning them to attract venture and industry partners. Awards will include significant financial resources in addition to therapeutic development and project management expertise.

All faculty at the rank of assistant, associate, or full professor in the Faculty of Medicine (i.e., faculty at HMS, HMS-affiliated institutions, and HSDM) are eligible to apply for funding as lead PI. The Blavatnik Family Foundation will provide the funds for the awards, which will be administered by Harvard via a grant to the PI’s institution and funded at a level of up to $1 million (total costs) over a period of two years.

The inaugural cycle of the Blavatnik Therapeutics Challenge Awards program was successfully completed in 2020. It is anticipated that up to five new awards will be made in the 2021 program cycle, with additional annual program cycles anticipated in 2022 and 2023.

When is the deadline?
Pre-proposals of up to four pages are due by March 1, 2021, at 5 p.m.

How do I learn more about this opportunity?
More details on the RFP and submission process are attached and can be found on the program website: https://btca.hms.harvard.edu.

For questions about the submission, review, and selection process for pre-proposals, contact Ifat Rubin-Bejerano (ifat_rubin-bejerano@hms.harvard.edu ), HMS director of translational research programs.

 
7. Breast Cancer Alliance – Exceptional Project Grants

Letters of intent are now being accepted by the Executive Committee on Research (ECOR) for the Breast Cancer Alliance Exceptional Project Grant.

What are they?
The Breast Cancer Alliance invites clinical doctors and research scientists at any stage of their careers whose primary focus is breast cancer to apply for an Exceptional Project Grant. This award recognizes creative, unique and innovative research.

MGH is allowed to submit a maximum of 2 LOIs to the sponsor.

How much is the award?
The award is $100,000 for one year. Administrative costs, which are included in the $100,000 award, must be limited to 8% of grant funds. ECOR policy states that for MGH investigators selected through a competitive process as the institutional nominee in which the grant will bring in less than 15% indirect cost (IDC), ECOR will cover the IDC gap up to a maximum of $50,000 per year.

When is the deadline?  

MGH letter of intent deadline: Monday, March 1, 2021 at 5:00pm
BCA letter of intent deadline: Monday, April 5, 2021

What are the internal guidelines?
Please submit a 1-2 page letter of intent, along with a NIH biosketch, to ecor@mgh.harvard.edu

Be sure to include the following information:

  1. Applicant's name, job title, and the applicant's contact information
  2. State the project title and hypothesis, outline the research aim(s) and methods
  3. A brief discussion of the project's potential impact

In the event that there are more than 2 applicants, the internal LOI will be used to assess if a review and selection process will be needed. ECOR will notify all interested applicants by March 22, 2021.

How do I learn more about the opportunity?
Breast Cancer Alliance Exceptional Project Grants – Click here

 
8. Thinking about an EBP, QI, or research project? Special funding opportunity for DNP & advanced practice nurses!

The Massachusetts General Hospital Nurses’ Alumni Association (MGHNAA) Grant, supported by and named for the MGH School of Nursing Nurses Alumni Association with oversight by the Yvonne L. Munn Center for Nursing Research at MGH, provides 2 years of funding for an EBP, QI, or research project.  Up to $3000 is available to implement a project to advance nursing science and improve outcomes for the nursing workforce, patients, or families.

  • Proposal deadline EXTENDED: Now due: March 1, 2021
  • Applicant is a graduate of a DNP program or an advanced practice nurse graduate of a MSN program.
  • Proposed project is EBP, Quality Improvement, or Original Research
  • Applicant is employed full-time at MGH.

For more information about this Grant, including eligibility requirements, application, instructions, and deadlines, please visit the Munn Center website: https://www.mghpcs.org/munncenter/Nurses-Alumni-Grant.asp or email Jennifer Cahill, PhD, RN: jennifer.cahill@mgh.harvard.edu

 
9. HMS Foundation Funds

Each year several foundations invite HMS faculty and postdocs to apply for their fellowships and grants, which serve as critical funding at the early stages of a research career.  Interested investigators must first apply for the HMS nomination through the HMS Foundation Funds office, and a committee will select the final candidates to submit applications to the sponsors.

Awards include:
•            Brain Research Foundation Scientific Innovations Award
•            Edward Mallinckrodt, Jr. Foundation Grant
•            Greenwall Faculty Scholars Program
•            Herbert W. Nickens Faculty Fellowship
•            Karin Grunebaum Cancer Research Foundation Faculty Fellowship
•            Rita Allen Foundation Scholars Award
•            Searle Scholars Program
•            W.T. Grant Scholars Program

Faculty and postdocs interested in applying for any of the awards listed above can apply for the HMS nomination by submitting an application online no later than Monday, March 1, 2021 at 11:30PM. For information on application guidelines, click here.

For some awards, MGH receives invitations to submit their own nominations. In this case, MGH faculty must first apply for the MGH nomination through ECOR and a committee at MGH will select the final MGH candidate(s) to submit applications to the foundations. Click here to view a chart of the current opportunities and the Institution that MGH faculty should apply through. Internal announcements are forthcoming.

MGH is invited to submit their own application for the following opportunities:
Breast Cancer Alliance Exceptional Project Grants
Breast Cancer Alliance Young Investigator Grants
Charles H. Hood Foundation Major Grants Initiative to Advance Child Health
Pew Scholars Program in the Biomedical Sciences

Please direct all inquiries regarding the application process at HMS to Clare Lamont, Program Coordinator, Office for Academic and Clinical Affairs, 617-432-7463, clare_lamont@hms.harvard.edu .  If you have questions regarding the MGH application process, please email MGH ECOR, ecor@mgh.harvard.edu.

 
10. Harrington Discovery Institute Grant Opportunities

HARRINGTON SCHOLAR-INNOVATOR AWARD
**M.D. required for eligibility. Open to physician-scientists in the U.S. and Canada.
Call Opens: March 8
Letters of Intent (LOI) Due: April 16, 2021

Harrington Discovery Institute (HDI) invites you to submit an LOI for the 2022 Harrington Scholar-Innovator Award. This grant supports all disease areas and is designed to advance your promising drug discovery research towards the clinic. In addition to grant funding, HDI provides guidance and oversight in all aspects of drug development, while taking no rights to intellectual property, which is retained by you/your institution.
  
To learn more about this award, click here.
To submit an online application, go to HDI’s grant system and create an account. 
Click here to view the FAQ.
Questions? Email HDIQuestions@HarringtonDiscovery.org.

ADDF-HARRINGTON SCHOLAR AWARD
** Ph.D. or M.D. or equivalent required for eligibility. Open to researchers in the U.S., U.K. and Canada.
Call Opens: March 2
Letters of Intent (LOI) Due: April 23, 2021

Harrington Discovery Institute (HDI) and the Alzheimer’s Drug Discovery Foundation (ADDF) invite you to submit an LOI for the 2021 ADDF-Harrington Scholar Award. This grant is designed to accelerate the translation of academic discoveries into medicines for treating, preventing, or curing patients with Alzheimer’s disease and related dementias. Of particular interest are targets related to proteostasis and epigenetics. Researchers working on drug development programs that are relevant to, but not presently focused on, the Alzheimer’s field are encouraged to apply. In addition to grant funding, HDI provides guidance and oversight in all aspects of drug development, while taking no rights to intellectual property, which is retained by you/your institution.

 
11.  NIH Research Supplements to Promote Diversity in Health-Related Research

Fostering diversity in the scientific research workforce is a key component of the NIH strategy to identify, develop, support and maintain the quality of our scientific human capital NOT-OD-20-031.

This administrative supplement is designed to provide support for research experiences for individuals from diverse backgrounds throughout the continuum from high school to the faculty level. Continuation of this program in the future will depend on the evaluation of the career outcomes of the supported individuals as well as continuing assessments of the diversity of the scientific workforce.

Please click here to learn more.

 
12. 2021 Request for Applications: Andrew L. Warshaw, M.D, Institute for Pancreatic Cancer Research

The Andrew L. Warshaw, M.D., Institute for Pancreatic Cancer Research invites applications for pilot grant funding from MGH investigators. Applications are welcome from new investigators, established investigators in the field of pancreatic cancer, as well as senior investigators who have not previously worked in this area. The Institute is particularly interested in research directed towards identifying specific causes of pancreatic cancer; early detection, understanding factors that promote tumor growth; novel imaging modalities; understanding mechanisms of resistance to existing chemotherapy and radiation, as well as exploring novel therapeutic approaches. Basic, translational, and clinical research projects will be considered.

Awards

Up to two pilot grants will be funded for one year at $50,000 (direct costs).

Application Guidelines

  • Principal Investigator’s NIH formatted biosketch (2-page maximum) including key references emphasizing the Principal Investigator’s publications.
  • Three-page proposal including:
  • Project title with contact information for the Principal Investigator.
  • Abstract (200 words).
  • Description of project, including background, aims and experimental approaches. Graphs, tables and references are not included in the 3-page maximum.
  • Include a budget and budget justification.

Important Dates

  • Due date for proposals is Wednesday, March 31, 2021, 5:00PM
  • Proposals will be reviewed by the executive committee of the Warshaw Institute in mid-April, and awardees will be notified by May 1, 2021.
  • Funding will begin on July 1, 2021.

Submission Instructions

  • Please submit a single PDF (and address inquiries) to: Daniel Salvati, Administrative Director for Research, Department of Surgery; dsalvati@mgh.harvard.edu
 
13. Limited Submission Funding Opportunities

We ask that all MGH Investigators interested in applying for any limited submission award submit a Letter of Intent (see detailed instructions below) to the MGH Executive Committee on Research (ECOR) by the deadline indicated for each award to be considered to receive an institutional nomination.

Process            
Submit a one- to two-page Letter of Intent (LOI) to the MGH Executive Committee on Research (ECOR) via email to ecor@partners.org.  In addition to your LOI, please include an NIH Biosketch.

The letter of intent should include:

  • Name of the Principal Investigator with appropriate contact information
  • A descriptive title of the potential application
  • Brief description of the project
  • Brief description of why you specifically should be selected to receive institutional nomination for this award


If there is more than one MGH investigator interested in applying for each limited submission award, the LOIs will be used to assess candidates and a review and selection process will take place.

Current Limited Submission Funding Opportunities                                                                                                                                              
Please click here for more information and for our internal deadlines.

  • Mentored Research Experiences for Genetic Counselors (R25)
  • Research Experience in Genomic Research for Data Scientists (R25)
  • Clinical and Translational Science Award (U54 Clinical Trial Optional) – NEW!
  • Tuberculosis Research Advancement Centers (P30 Clinical Trials Not Allowed)
  • Human Immunology Project Consortium (HIPC) (U19 Clinical Trial Optional)
  • Human Immunology Project Consortium (HIPC) Coordinating Center (U01 Clinical Trial Not Allowed)
  • Screening for Conditions by Electronic Nose Technology (SCENT) (U01 Clinical Trial Optional)
  • Undergraduate Research Training Initiative for Student Enhancement (U-RISE) (T34) – NEW!
  • New Chemistries for Un-drugged Targets through A Specialized Platform for Innovative Research Exploration (ASPIRE) Collaborative Research Program (UG3/UH3 Clinical Trials Not Allowed)

 

If there is a limited submission funding opportunity you do not see listed above or you have any additional questions, please let us know at ecor@mgh.harvard.edu.

 
14. Foundation Funding Opportunities

Please contact Corporate & Foundation Relations in the Office of Development at devcfr@mgh.harvard.edu if you wish to submit a proposal in response to any of these opportunities.  Note that proposals are still routed through the standard Insight/Research Management process.

Please be aware that any grant that brings in less than 15% in indirect costs (IDC) will need to be supplemented up to the 15% equivalent by existing investigator or departmental sundry funds. Resolution of this issue must occur prior to submitting a proposal.  Training fellowships from foundations, public charity, and non-profit organizations are excluded from this minimum IDC requirement.

Week of 02/26/21

  • ADDF-Harrington Scholar Program, Alzheimer's Drug Discovery Foundation (ADDF). $600,000. Deadline: April 23
  • Clinical Research Grant, American Speech-Language-Hearing Foundation (ASHFoundation). $75,000. Deadline: April 19
  • Open Call for Research Proposals, Angelman Syndrome Foundation, Inc. (ASF). $200,000. Deadline: April 15
  • Research Grants, Biostime Institute for Nutrition and Care (BINC) – Geneva. $109,000. Deadline: March 31
  • Research Proposals and Postdoctoral Research Fellowships, Cystinosis Research Foundation. $75,000. Deadline: April 19
  • Genetic Intellectual Disability Grants, Fondation Jérôme Lejeune. $89,000. Deadline: March 8
  • Fauci Fellowships, National Italian American Foundation (NIAF) NEW! $50,000. Deadline: April 1
  • Early Identification and Diagnosis of Axial Spondyloarthritis, Pfizer Global Medical Grants (GMG) NEW! $300,000. Deadline: March 29
  • Systems for Action: Systems and Services Research to Build a Culture of Health, Robert Wood Johnson Foundation (RWJF) NEW! $500,000. Deadline: April 30
  • Research Funding Program, Sanfilippo Children's Foundation. $239,000. Deadline: March 24
  • Grants for Research and Development Projects, Stiftelsen Promobilia - Promobilia Foundation. $50,000. Deadline: March 11
Back to top
In Case You Missed It
 
Reminders of recently posted funding opportunities, deadlines and events

Strengthen research skills, support health equity with the 2021 Butler-Williams Scholars Program

The Yvonne L. Munn Predoctoral Research Grant for PhD Nursing Students

MGH Town Hall Meeting Recordings

MGB Community Connects

Mentor MGB

MGH Employee Testing Center

Check out the Coronavirus Resource Guide for MGH Researchers!

Meditation Mondays with Dr. Darshan Mehta

NIH Update for Week Ending February 26, 2021

PCORI - Click here for the latest funding opportunities from the Patient-Centered Outcomes Research Institute (PCORI).

Looking for something you saw in a previous Research News release? Check out our archive!

Back to top
 
RESOURCES  

ECOR Website

Mass General Research Institute

MGH Research Intranet

Research Help and How-To

Your email address is currently listed as:%%emailaddr%%.

Click here to edit your profile or to change your email address for receipt of information about MGH Research.

Click here to subscribe to MGH Research Email announcements.
Executive Committee On Research (ECOR) Massachusetts General Hospital
125 Nashua Street, Suite 822, Boston, MA 02114
ecor@mgh.harvard.edu